Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor.

<h4>Background</h4>Health assessment of the transplanted organ is very important due to the relationship of long-term survival of organ transplant recipients and health organ maintenance. Nowadays, the measurement of cell-free DNA from grafts in the circulation of transplant recipients h...

Full description

Saved in:
Bibliographic Details
Main Authors: Hada C Macher, Gonzalo Suárez-Artacho, Juan M Guerrero, Miguel A Gómez-Bravo, Sara Álvarez-Gómez, Carmen Bernal-Bellido, Inmaculada Dominguez-Pascual, Amalia Rubio
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0113987&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850190523416969216
author Hada C Macher
Gonzalo Suárez-Artacho
Juan M Guerrero
Miguel A Gómez-Bravo
Sara Álvarez-Gómez
Carmen Bernal-Bellido
Inmaculada Dominguez-Pascual
Amalia Rubio
author_facet Hada C Macher
Gonzalo Suárez-Artacho
Juan M Guerrero
Miguel A Gómez-Bravo
Sara Álvarez-Gómez
Carmen Bernal-Bellido
Inmaculada Dominguez-Pascual
Amalia Rubio
author_sort Hada C Macher
collection DOAJ
description <h4>Background</h4>Health assessment of the transplanted organ is very important due to the relationship of long-term survival of organ transplant recipients and health organ maintenance. Nowadays, the measurement of cell-free DNA from grafts in the circulation of transplant recipients has been considered a potential biomarker of organ rejection or transplant associated complications in an attempt to replace or reduce liver biopsy. However, methods developed to date are expensive and extremely time-consuming. Our approach was to measure the SRY gene, as a male organ biomarker, in a setting of sex-mismatched female recipients of male donor organs.<h4>Methods</h4>Cell-free DNA quantization of the SRY gene was performed by real-time quantitative PCR beforehand, at the moment of transplantation during reperfusion (day 0) and during the stay at the intensive care unit. Beta-globin cell-free DNA levels, a general cellular damage marker, were also quantified.<h4>Results</h4>Beta-globin mean values of patients, who accepted the graft without any complications during the first week after surgery, diminished from day 0 until patient stabilization. This decrease was not so evident in patients who suffered some kind of post-transplantation complications. All patients showed an increase in SRY levels at day 0, which decreased during hospitalization. Different complications that did not compromise donated organs showed increased beta-globin levels but no SRY gene levels. However, when a donated organ was damaged the patients exhibited high levels of both genes.<h4>Conclusion</h4>Determination of a SRY gene in a female recipient's serum is a clear and specific biomarker of donated organs and may give us important information about graft health in a short period of time by a non-expensive technique. This approach may permit clinicians to maintain a close follow up of the transplanted patient.
format Article
id doaj-art-cfbd41727b104cfaac5b0a57fc5847de
institution OA Journals
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-cfbd41727b104cfaac5b0a57fc5847de2025-08-20T02:15:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01912e11398710.1371/journal.pone.0113987Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor.Hada C MacherGonzalo Suárez-ArtachoJuan M GuerreroMiguel A Gómez-BravoSara Álvarez-GómezCarmen Bernal-BellidoInmaculada Dominguez-PascualAmalia Rubio<h4>Background</h4>Health assessment of the transplanted organ is very important due to the relationship of long-term survival of organ transplant recipients and health organ maintenance. Nowadays, the measurement of cell-free DNA from grafts in the circulation of transplant recipients has been considered a potential biomarker of organ rejection or transplant associated complications in an attempt to replace or reduce liver biopsy. However, methods developed to date are expensive and extremely time-consuming. Our approach was to measure the SRY gene, as a male organ biomarker, in a setting of sex-mismatched female recipients of male donor organs.<h4>Methods</h4>Cell-free DNA quantization of the SRY gene was performed by real-time quantitative PCR beforehand, at the moment of transplantation during reperfusion (day 0) and during the stay at the intensive care unit. Beta-globin cell-free DNA levels, a general cellular damage marker, were also quantified.<h4>Results</h4>Beta-globin mean values of patients, who accepted the graft without any complications during the first week after surgery, diminished from day 0 until patient stabilization. This decrease was not so evident in patients who suffered some kind of post-transplantation complications. All patients showed an increase in SRY levels at day 0, which decreased during hospitalization. Different complications that did not compromise donated organs showed increased beta-globin levels but no SRY gene levels. However, when a donated organ was damaged the patients exhibited high levels of both genes.<h4>Conclusion</h4>Determination of a SRY gene in a female recipient's serum is a clear and specific biomarker of donated organs and may give us important information about graft health in a short period of time by a non-expensive technique. This approach may permit clinicians to maintain a close follow up of the transplanted patient.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0113987&type=printable
spellingShingle Hada C Macher
Gonzalo Suárez-Artacho
Juan M Guerrero
Miguel A Gómez-Bravo
Sara Álvarez-Gómez
Carmen Bernal-Bellido
Inmaculada Dominguez-Pascual
Amalia Rubio
Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor.
PLoS ONE
title Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor.
title_full Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor.
title_fullStr Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor.
title_full_unstemmed Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor.
title_short Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor.
title_sort monitoring of transplanted liver health by quantification of organ specific genomic marker in circulating dna from receptor
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0113987&type=printable
work_keys_str_mv AT hadacmacher monitoringoftransplantedliverhealthbyquantificationoforganspecificgenomicmarkerincirculatingdnafromreceptor
AT gonzalosuarezartacho monitoringoftransplantedliverhealthbyquantificationoforganspecificgenomicmarkerincirculatingdnafromreceptor
AT juanmguerrero monitoringoftransplantedliverhealthbyquantificationoforganspecificgenomicmarkerincirculatingdnafromreceptor
AT miguelagomezbravo monitoringoftransplantedliverhealthbyquantificationoforganspecificgenomicmarkerincirculatingdnafromreceptor
AT saraalvarezgomez monitoringoftransplantedliverhealthbyquantificationoforganspecificgenomicmarkerincirculatingdnafromreceptor
AT carmenbernalbellido monitoringoftransplantedliverhealthbyquantificationoforganspecificgenomicmarkerincirculatingdnafromreceptor
AT inmaculadadominguezpascual monitoringoftransplantedliverhealthbyquantificationoforganspecificgenomicmarkerincirculatingdnafromreceptor
AT amaliarubio monitoringoftransplantedliverhealthbyquantificationoforganspecificgenomicmarkerincirculatingdnafromreceptor